Related coverage linked through entity extraction aliases.
Aug 24, 2026
A study in Diabetologia shows type 2 diabetes in lean Africans is driven by insulin shortage, not insulin resistance, and may require different treatment than standard guidelines. The study analyzed data from over 3,300 African adults and found distinct complication patterns between lean and overweight patients.
Jul 31, 2026
Lawmakers opened national security probes into Merck, AbbVie and others over China drug trials. A survey finds China closing in on U.S. biotech leadership, and HHS launched clinical trial reforms to counter the rise.
Aug 07, 2026
A drug-free wearable device that generates low-intensity electric fields reduced tumor growth and spread in preclinical models of triple-negative breast cancer. The treatment appeared to boost immune activity around tumors and will be tested in an upcoming NIH-sponsored clinical trial.
Aug 07, 2026
Biotechnology is now a national security issue in Washington, with investment restrictions, export controls, and procurement bans targeting China. The Pentagon designated WuXi AppTec as a Chinese military company, sparking a legal challenge. Policymakers also warn about supply chain dependence, biosecurity, and the dual-use dilemma.
Jul 28, 2026
AI identified rectal cancer patients who benefit from adding irinotecan to chemoradiotherapy, cutting recurrence and death risk. Separate research finds most online AI-cancer information is low quality and too complex for patients.
Jun 26, 2026
Recent studies show progress in cancer treatment: HDAC inhibitors enhance pancreatic cancer therapy, AI-guided radiation targets glioblastoma, and reprogrammed tumor cells trigger antitumor immunity. Nanoparticle drug delivery for brain cancer is also being explored.
Aug 04, 2026
Semaglutide may lower risks of adult-onset seizures and alcohol-related hospitalizations, new studies find. Brazil approved five semaglutide injectables, and a commentary updates obesity care with GLP-1 drugs.
Aug 02, 2026
Federal and international funders have announced life sciences and biotech funding opportunities: NIH awards up to $30 million, NSF fellowships, and roundups exceeding $900 million. Scholarships and grants are open worldwide, with AI and local eligibility as key criteria.
Aug 01, 2026
A study of over 85,000 women found that insurance coverage and healthcare access significantly affect folic acid use, increasing preventable birth defect risks. The findings support fortification efforts, while a University of Houston initiative aims to address pharmacy access barriers.
Jul 21, 2026
A federal judge blocked grant terminations based on changed priorities; OMB proposes political control over awards. Ph.D. enrollment declines as funding uncertainty persists, and science leaders urge advocacy.
May 26, 2026
New studies show how mRNA fragments activate backup genes, how RISC assembly uses target mRNA, and how Rrm4 transports mRNA in fungi — pointing to new therapeutic approaches.
Jul 09, 2026
Two new studies in IBD genetics show that polygenic risk scores can predict disease severity in Danish patients, and that ancestry-specific variants in Hispanic populations reveal novel risk loci and differential effects of known genes. These findings advance precision medicine by improving risk prediction and highlighting the need for diverse genetic research.
Aug 04, 2026
NIH expanded its All of Us dataset, linking 535,000 whole genome sequences to 482,000 EHRs from 747,000 participants. The release includes 1.3 billion variants and aims to advance precision medicine, prioritizing underrepresented populations.
Jun 08, 2026
UKCA approval was granted for the LVOne stroke blood test, piloting with London Ambulance Service. A phase 2 trial showed LT 3001 is safe up to 24 hours post-stroke; 'leaky core' imaging links barrier disruption to worse outcomes.
Jul 31, 2026
Penn joined 35 universities in an amicus brief supporting Harvard’s lawsuit against a $2 billion federal research funding freeze. The brief warns that such cuts endanger basic research and innovation, as Penn itself faces over $400 million in recent funding freezes and cuts.
Jul 30, 2026
The Astera Institute invests $500M in Radial to build AI-friendly biology infrastructure. Meanwhile, AI tools flood computer science publishing, AI-assisted NIH grants lean toward less innovation, and a new platform lets AI agents hire human helpers.
Jul 28, 2026
Systematic review confirms hepatitis B birth dose is safe and effective; separate study finds childhood vaccination linked to significantly lower HBV coinfection in people with HIV.
Jul 25, 2026
Flow chemistry, laboratory mixer, and industrial extruder markets are projected to grow significantly through 2035, driven by pharmaceutical continuous manufacturing, high R&D funding, and sustainability trends. Flow chemistry is expected to reach $12 billion, while laboratory mixers could hit $29.6 billion. Key players include Merck KGaA, BASF, and Lonza.
Jul 24, 2026
The White House issued a report urging federal agencies to fund scientific research beyond university labs, favoring individual researchers and multiyear grants. Critics call the plan a rhetorical move that could undermine the existing research enterprise, while the administration frames it as necessary for complex, large-team science.
Jul 23, 2026
The FDA has finalized the revocation of Orange B and proposed revoking Citrus Red No. 2, while exercising enforcement discretion to permit ‘no artificial colors’ claims on foods that avoid petroleum‑based dyes. The actions are part of a broader initiative to phase out synthetic dyes and fast‑track natural alternatives.
